Literature DB >> 1096789

Effects of drugs on uric acid in man.

W N Kelley.   

Abstract

In this review the drugs capable of increasing or lowering the serum urate concentration are considered with regard to mechanism of action and significance of the effect, where known. Several hypouricemic agents, probenecid, sulfinpyrazone, and allopurinol, are considered in further detail because of their major clinical importance. No effort has been made, however, to summarize the relative clinical indications for each agent. In addition, in those cases where specific details could not be included because of limitation of space, the appropiate reference has been given.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096789     DOI: 10.1146/annurev.pa.15.040175.001551

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN: 0066-4251            Impact factor:   13.820


  8 in total

1.  Plasma uric acid and plasma albumin in healthy subjects.

Authors:  L Ramsay; T Mitchell; J Shelton
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

2.  Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state.

Authors:  B Rosenkranz; C Fischer; P Jakobsen; A Kirstein Pedersen; J C Frölich
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  S Brosh; P Boer; B Kupfer; A de Vries; O Sperling
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

Review 4.  Bipolar disorder: candidate drug targets.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Mt Sinai J Med       Date:  2008 May-Jun

Review 5.  Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.

Authors:  E H Margulies; A M White; S Sherry
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

6.  Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors.

Authors:  Takuji Hosoya; Shunya Uchida; Shigeru Shibata; Naoko H Tomioka; Makoto Hosoyamada
Journal:  Br J Pharmacol       Date:  2020-02-18       Impact factor: 8.739

7.  Allopurinol influences aminophenazone elimination.

Authors:  M Barry; J Feely
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

8.  A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients.

Authors:  Meenu Pichholiya; Arvind Kumar Yadav; S K Luhadia; Jameela Tahashildar; M L Aseri
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.